age related macular degeneration
Pivotal discoveries in age-related macular degeneration
A team of researchers, led by University of Kentucky ophthalmologist Dr. Jayakrishna Ambati, has discovered a molecular mechanism implicated in geographic atrophy, the major cause of untreatable blindness in the industrialized world.
Their ar…
A dry AMD treatment?; some long-term diabetics escape PDR
CHICAGO — At the American Academy of Ophthalmology (AAO) — Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting today, researchers report progress on two top eye disease challenges: treating advanced “dry” age-related macular degen…
Certain new therapies for age-related eye disease do not appear to increase heart risks
Newer treatments for age-related macular degeneration (AMD) — including an intravitreous (into the eye) injection of a chemotherapy drug and use of a related compound approved for use against the eye disease — do not appear to be associated with a…
Scientists link brain plaques in Alzheimer?s disease to eye disease
Scientists at the Center for the Study of Macular Degeneration at the Neuroscience Research Institute of the University of California, Santa Barbara have found a link between the brain plaques that form in Alzheimer?s disease and the deposits in the retina that are associated with age-related macular degeneration (AMD). AMD is a disease that leads to loss of central vision and affects 5 to 10 percent of the population over age 60.
NASA to showcase innovative research for treating blindness
A technology designed to restore vision in patients suffering from age-related blindness will be demonstrated by a scientist at NASA Ames Research Center in California’s Silicon Valley today. Developed by NASA Ames in conjunction with the Stanford University School of Medicine, the “Vision Chip” may help improve age-related macular degeneration, the number one cause of blindness in the elderly. “Nanotechnology that could restore vision is an exciting example of how NASA science and engineering, origially intended for outer space, can return enormous dividends for everyday life here on Earth,” said Dr. David J. Loftus, a member of both the Life Sciences Division and the Integrated Product Team on Devices and Nanotechnology at NASA Ames.